Revolutionizing Renal Care with Predictive Analytics for CKD
Chronic Kidney Disease (CKD) is a common and growing condition, affecting about half of the Medicare population and of diabetics. In the United States, the lifetime risk of CKD for 30-year-olds is now greater than half, and the prevalence of CKD is projected to rise significantly over the next 15 years.
Current methods of predicting which CKD patients will progress to renal failure and require dialysis or transplant have low accuracy rates, causing great anxiety and suboptimal care. Without accurate risk prediction, many patients are over-treated, effectively wasting limited resources and negatively impacting outcomes. Conversely, other patients may receive inadequate treatment, restricting options to only the most costly and least desirable interventions.
Watch this on-demand webinar with Dr. Navdeep Tangri, developer of the Kidney Failure Risk Equation, which revolutionizes the way CKD patients are managed by leveraging laboratory data to accurately predict the risk of kidney failure in patients with CKD.
Navdeep Tangri, MD, Ph.D., FRCP(C)
Associate Professor in the Division of Nephrology, Department of Medicine and the Department of Community Health Science
University of Manitoba
Navdeep Tangri is an attending physician and Associate Professor in the Division of Nephrology, Department of Medicine and the Department of Community Health Sciences at the University of Manitoba. Dr. Tangri’s research program is clinical and translational, and focused on improving clinical decision making for patients with advanced chronic kidney disease. He developed and validated the Kidney Failure Risk Equation to predict the need for dialysis in patients with CKD, and is presently engaged in multiple validation and implementation exercises to increase the uptake of the KFRE. In addition, Dr. Tangri is conducting a large prospective study on frailty, physical and cognitive function in advanced DKD, as well as comparative effectiveness studies on the safety and effectiveness of medical therapies in this population. He has published more than 120 manuscripts and presented at multiple national and international scientific meetings. He sits on the editorial board of the American Journal of Kidney Disease, Canadian Journal of Kidney Health and Disease, and is Section Editor for the Epidemiology and Prevention Issue of Current Opinion in Nephrology and Hypertension. He has active grants from the Canadian Institute of Health Research, the Kidney Foundation of Canada, and the Manitoba Health Research Council.
Eleanor Herriman, MD, MBA
Chief Medical Informatics Officer
Eleanor Herriman is the Chief Medical Informatics Officer at Viewics. She is a former Senior Fellow with Professor Michael Porter at Harvard Business School’s Institute for Strategy and Competitiveness. Prior career experience includes: market research and strategy services to the pathology and laboratory industries at G2 Intelligence, healthcare strategy consulting at Bain & Company, and multiple startup medical technology ventures. She holds a Doctor of Medicine degree from Baylor College of Medicine and was awarded the President’s Scholarship. She also holds a Masters in Business Administration from Harvard University Graduate School of Business Administration as a Baker Scholar and a Bachelors of Science in electrical engineering from Rice University, Magna Cum Laude, with a minor in bioengineering.
VP of Products
Dave Garnett is the VP of Products at Viewics. He is a multi-time entrepreneur and recognized authority on cloud computing, Big Data analytics, and entrepreneurship. He founded his first company at 19 years old while studying Philosophy at Santa Clara University. He leads product management, product marketing, and user experience to transform the medical analytics industry by providing actionable clinical and operational insights to laboratories, hospitals, and health systems. Prior to joining Viewics, he held senior executive management positions at both public and private companies focusing on Big Data analytics, including Actuate Corporation (acquired by OpenText), Gluster (acquired by Red Hat), and 24-7 Customer (Prospective 2016 IPO). Additionally, he founded Axcient, a venture-funded data backup and disaster recovery SaaS company; Digital Data Storage (acquired in 2000), which provided an innovative approach to transformation of paper medical records to a HIPAA-compliant electronic format; and Feedheed, a predictive analytics company focusing on forecasting employee turnover.
- How CKD is burdening our healthcare system, and the need for better care management tools
- How the Kidney Failure Risk Equation was researched, developed, and validated
- How Viewics is implementing CKD predictive analytics to automatically deliver risk information to clinicians and issue customized, educational reports to patients and clinicians